Overview

Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

Status:
Completed
Trial end date:
2018-10-16
Target enrollment:
Participant gender:
Summary
The objective of this survey is to confirm the safety of Suglat Tablets
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin